This inventor holds 35 USPTO granted patents and 1 published patent application and 10 EPO patents, primarily in Covalent Tethering. Top assignees: Promega Corporation, Nycomed Amersham Plc, Amersham Biosciences Corp. Active years: 2002-2021.
Location History:
- Bethlehem, PA (US) (2002 - 2003)
- Columbus, OH (US) (2005)
- Arroya Grande, CA (US) (2016)
- Arroyo Grande, CA (US) (2003 - 2021)
Company Filing History:
29 out of 417 
2 out of 16 
1 out of 15 Years Active: 2002-2021
Areas of Expertise:
Title: The Innovative Mind of Mark McDougall
Introduction
Mark McDougall, located in Arroyo Grande, California, is a distinguished inventor with an impressive portfolio of 35 patents. His work focuses primarily on advancing the field of biochemistry, particularly in relation to hydrolases and fusion proteins.
Latest Patents
Among his latest contributions to the scientific community are two notable patents. The first patent involves the covalent tethering of functional groups to proteins, wherein a mutant hydrolase, optionally fused to a protein of interest, forms a more stable bond with a substrate than its wild-type counterpart. This innovation facilitates various applications by providing substrates for hydrolases that comprise one or more functional groups, alongside methods for utilizing both the mutant hydrolase and the substrates.
The second patent describes a method of immobilizing a protein or molecule through a mutant dehalogenase that is bound to an immobilized dehalogenase substrate. Like the first, this mutant hydrolase features at least two amino acid substitutions compared to the wild-type, enhancing its stability and functionality.
Career Highlights
Mark has built a remarkable career at various leading companies in the biotechnology sector, including Promega Corporation and Nycomed Amersham Plc. His experiences in these organizations have played a significant role in the development of his innovative ideas and patented technologies.
Collaborations
Throughout his career, Mark has worked alongside notable colleagues, including Dieter Klaubert and Chad Zimprich. These collaborations have likely contributed to his successful endeavors in the realm of patentable inventions.
Conclusion
Mark McDougall's contributions to the field of biotechnology through his 35 patents reflect his commitment to innovation and excellence. His focus on improving hydrolases and fusion proteins not only advances scientific understanding but also paves the way for future applications in various industries.